Samjin Pharm (005500) - Cash Flow Conversion Efficiency

Latest as of September 2025: -0.005x

Based on the latest financial reports, Samjin Pharm (005500) has a cash flow conversion efficiency ratio of -0.005x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩-1.43 Billion ≈ $-969.50K USD) by net assets (₩264.51 Billion ≈ $179.25 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Samjin Pharm net asset quality index to measure how much of total assets are equity-financed.

Samjin Pharm - Cash Flow Conversion Efficiency Trend (2013–2024)

This chart illustrates how Samjin Pharm's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check how high is Samjin Pharm's earnings quality to evaluate the quality of earnings relative to operating cash generation.

Samjin Pharm Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Samjin Pharm ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
AGV Products Corp TW:1217	0.017x
Donpon Precision TWO:3290	0.001x
UPDATER SERVICES LIMITED NSE:UDS	0.032x
Yungjin Pharm Co Ltd KO:003520	0.078x
Freightcar America Inc NASDAQ:RAIL	0.066x
Alcatel Lucent Teletas Telekomunikasyon AS IS:ALCTL	-0.122x
Shanghai Longyun Advg & Media SHG:603729	0.031x
Berkeley Energia Ltd AU:BKY	0.000x

Annual Cash Flow Conversion Efficiency for Samjin Pharm (2013–2024)

The table below shows the annual cash flow conversion efficiency of Samjin Pharm from 2013 to 2024. For the full company profile with market capitalisation and key ratios, see Samjin Pharm market cap and net worth.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	₩261.66 Billion ≈ $177.32 Million	₩38.15 Billion ≈ $25.86 Million	0.146x	+364.31%
2023-12-31	₩265.36 Billion ≈ $179.83 Million	₩8.33 Billion ≈ $5.65 Million	0.031x	-49.90%
2022-12-31	₩275.86 Billion ≈ $186.95 Million	₩17.29 Billion ≈ $11.72 Million	0.063x	-38.75%
2021-12-31	₩234.17 Billion ≈ $158.69 Million	₩23.97 Billion ≈ $16.24 Million	0.102x	-8.44%
2020-12-31	₩213.46 Billion ≈ $144.66 Million	₩23.86 Billion ≈ $16.17 Million	0.112x	-6.60%
2019-12-31	₩197.47 Billion ≈ $133.83 Million	₩23.63 Billion ≈ $16.02 Million	0.120x	-18.32%
2018-12-31	₩205.32 Billion ≈ $139.14 Million	₩30.08 Billion ≈ $20.39 Million	0.147x	-23.97%
2017-12-31	₩193.47 Billion ≈ $131.11 Million	₩37.28 Billion ≈ $25.27 Million	0.193x	-32.79%
2016-12-31	₩169.69 Billion ≈ $115.00 Million	₩48.66 Billion ≈ $32.97 Million	0.287x	+124.21%
2015-12-31	₩148.06 Billion ≈ $100.34 Million	₩18.94 Billion ≈ $12.83 Million	0.128x	-50.26%
2014-12-31	₩126.04 Billion ≈ $85.42 Million	₩32.41 Billion ≈ $21.96 Million	0.257x	+293.92%
2013-12-31	₩112.98 Billion ≈ $76.57 Million	₩7.37 Billion ≈ $5.00 Million	0.065x	--

About Samjin Pharm

KO:005500 Korea Drug Manufacturers - Specialty & Generic

Market Cap

$152.02 Million

₩224.32 Billion KRW

Market Cap Rank

#17623 Global

#723 in Korea

Share Price

₩18300.00

Change (1 day)

+0.60%

52-Week Range

₩17010.00 - ₩24700.00

All Time High

₩50479.08